These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9497260)

  • 21. The Analysis of Variants in the General Population Reveals That
    Citro V; Cimmaruta C; Monticelli M; Riccio G; Hay Mele B; Cubellis MV; Andreotti G
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency.
    Cline A; Gao N; Flanagan-Steet H; Sharma V; Rosa S; Sonon R; Azadi P; Sadler KC; Freeze HH; Lehrman MA; Steet R
    Mol Biol Cell; 2012 Nov; 23(21):4175-87. PubMed ID: 22956764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of four novel PMM2 mutations in congenital disorders of glycosylation (CDG) Ia French patients.
    Vuillaumier-Barrot S; Hetet G; Barnier A; Dupré T; Cuer M; de Lonlay P; Cormier-Daire V; Durand G; Grandchamp B; Seta N
    J Med Genet; 2000 Aug; 37(8):579-80. PubMed ID: 10922383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency).
    Grünewald S; Schollen E; Van Schaftingen E; Jaeken J; Matthijs G
    Am J Hum Genet; 2001 Feb; 68(2):347-54. PubMed ID: 11156536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PMM2-CDG: phenotype and genotype in four affected family members.
    Bortot B; Cosentini D; Faletra F; Biffi S; De Martino E; Carrozzi M; Severini GM
    Gene; 2013 Dec; 531(2):506-9. PubMed ID: 23988505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital disorder of glycosylation type 1a in a macrosomic 16-month-old boy with an atypical phenotype and homozygosity of the N216I mutation.
    Neumann LM; von Moers A; Kunze J; Blankenstein O; Marquardt T
    Eur J Pediatr; 2003 Oct; 162(10):710-3. PubMed ID: 12905014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families.
    Bjursell C; Erlandson A; Nordling M; Nilsson S; Wahlström J; Stibler H; Kristiansson B; Martinsson T
    Hum Mutat; 2000 Nov; 16(5):395-400. PubMed ID: 11058896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effects of PMM2-CDG-Causing Mutations on the Folding, Activity, and Stability of the PMM2 Protein.
    Yuste-Checa P; Gámez A; Brasil S; Desviat LR; Ugarte M; Pérez-Cerdá C; Pérez B
    Hum Mutat; 2015 Sep; 36(9):851-60. PubMed ID: 26014514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new insight into PMM2 mutations in the French population.
    Le Bizec C; Vuillaumier-Barrot S; Barnier A; Dupré T; Durand G; Seta N
    Hum Mutat; 2005 May; 25(5):504-5. PubMed ID: 15844218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel nonsense mutation (R194X) in the PMM2 gene in a Japanese patient with congenital disorder of glycosylation type Ia.
    Ono H; Sakura N; Yamashita K; Yuasa I; Ohno K
    Brain Dev; 2003 Oct; 25(7):525-8. PubMed ID: 13129599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of novel mutations in a congenital disorder of glycosylation Ia patient with mixed Asian ancestry.
    Westphal V; Enns GM; McCracken MF; Freeze HH
    Mol Genet Metab; 2001 May; 73(1):71-6. PubMed ID: 11350185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal diagnosis in CDG1 families: beware of heterogeneity.
    Matthijs G; Schollen E; Cassiman JJ; Cormier-Daire V; Jaeken J; van Schaftingen E
    Eur J Hum Genet; 1998; 6(2):99-104. PubMed ID: 9781052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis of carbohydrate-deficient glycoprotein syndromes type I with normal phosphomannomutase activity.
    Freeze HH; Aebi M
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):167-78. PubMed ID: 10571010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycystic Kidney Disease with Hyperinsulinemic Hypoglycemia Caused by a Promoter Mutation in Phosphomannomutase 2.
    Cabezas OR; Flanagan SE; Stanescu H; García-Martínez E; Caswell R; Lango-Allen H; Antón-Gamero M; Argente J; Bussell AM; Brandli A; Cheshire C; Crowne E; Dumitriu S; Drynda R; Hamilton-Shield JP; Hayes W; Hofherr A; Iancu D; Issler N; Jefferies C; Jones P; Johnson M; Kesselheim A; Klootwijk E; Koettgen M; Lewis W; Martos JM; Mozere M; Norman J; Patel V; Parrish A; Pérez-Cerdá C; Pozo J; Rahman SA; Sebire N; Tekman M; Turnpenny PD; Hoff WV; Viering DHHM; Weedon MN; Wilson P; Guay-Woodford L; Kleta R; Hussain K; Ellard S; Bockenhauer D
    J Am Soc Nephrol; 2017 Aug; 28(8):2529-2539. PubMed ID: 28373276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early fatal course in siblings with CDG-Ia (caused by two novel mutations in the PMM2 gene): clinical, molecular and autopsy findings.
    Wurm D; Hänsgen A; Kim YJ; Lindinger A; Baghai A; Gortner L
    Eur J Pediatr; 2007 Apr; 166(4):377-8. PubMed ID: 16941129
    [No Abstract]   [Full Text] [Related]  

  • 36. Congenital disorder of glycosylation type Ia in a Malaysian family: clinical outcome and description of a novel PMM2 mutation.
    Thong MK; Fietz M; Nicholls C; Lee MH; Asma O
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S41-4. PubMed ID: 19165618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A deletion-insertion mutation in the phosphomannomutase 2 gene in an African American patient with congenital disorders of glycosylation-Ia.
    Tayebi N; Andrews DQ; Park JK; Orvisky E; McReynolds J; Sidransky E; Krasnewich DM
    Am J Med Genet; 2002 Mar; 108(3):241-6. PubMed ID: 11891694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical phenotype correlates to glycoprotein phenotype in a sib pair with CDG-Ia.
    Barone R; Sturiale L; Sofia V; Ignoto A; Fiumara A; Sorge G; Garozzo D; Zappia M
    Am J Med Genet A; 2008 Aug; 146A(16):2103-8. PubMed ID: 18629883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency).
    Carchon H; Van Schaftingen E; Matthijs G; Jaeken J
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):155-65. PubMed ID: 10571009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13.
    Matthijs G; Schollen E; Pirard M; Budarf ML; Van Schaftingen E; Cassiman JJ
    Genomics; 1997 Feb; 40(1):41-7. PubMed ID: 9070917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.